BAM
TECH icon

Belpointe Asset Management’s Bio-Techne TECH Stock Holding History

Belpointe Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-913
Closed -$67.7K – 3088
2023
Q1 		$67.7K Buy
913
+233
+34% +$18K ﹤0.01% 1538
2022
Q4 		$56.4K Buy
+680
New +$54K ﹤0.01% 1536
2022
Q2 		– Sell
-2,236
Closed -$242K – 1262
2022
Q1 		$242K Sell
2,236
-596
-21% -$61.5K 0.01% 828
2021
Q4 		$366K Buy
2,832
+424
+18% +$52K 0.02% 629
2021
Q3 		$292K Buy
2,408
+920
+62% +$112K 0.02% 692
2021
Q2 		$167K Buy
+1,488
New +$157K 0.01% 905

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Belpointe Asset Management's TECH Position: Q2 2023 in Review

Belpointe Asset Management sold out of Bio-Techne (TECH) in Q2 2023, closing a stake of 913 shares — an estimated $67.7K sold.

Belpointe Asset Management first reported a position in TECH in Q2 2021 and held it in 6 quarters. The position peaked at $366K in Q4 2021. 529 funds tracked by Wall St. Rank hold TECH as of Q2 2023.

  • Belpointe Asset Management reported no remaining Bio-Techne position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 913 Bio-Techne shares in Q2 2023, an estimated $67.7K.
  • Belpointe Asset Management first reported a position in Bio-Techne in Q2 2021 and held it in 6 quarters.
  • Belpointe Asset Management's Bio-Techne position peaked at $366K in Q4 2021.
  • 529 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.